Symbravo Shows Greater Migraine Improvement Compared With Oral CGRP Inhibitors
Meloxicam and rizatriptan (Symbravo, formerly AXS-07) is a CGRP medication approved for the acute treatment of migraine with or without aura.
Topical Medications as First-Line Treatment Options for Orofacial Pain
Researchers investigated the pharmacological management of chronic orofacial pain and provided guidance on its proper treatment.
FDA Grants Emergency Authorization to Aptitude’s COVID, Flu Test
The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.
Two New Stelara Biosimilars Now Available in US
Yesintek from Biocon Biologics and Pyzchiva from Sandoz will have a patient assistance program that includes benefits verification and copay support.
FDA Approves Updated Buprenorphine Label For Rapid Initiation Treatment
The updated label also includes alternative injection sites, such as the abdomen, thigh, buttock, or back of the upper arm.
Financial Incentives, Advocacy Drives Outpatient Practice Unification
Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.
Community Pharmacists as Experts on Complex Patient Encounters
Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.
Investigators Find Repurposing Amlodipine as Novel Treatment for ADHD
The study authors report that long-term daily administration of amlodipine induced behavioral changes in the rats during their open field test.
Mental Health First Aid Training Can Help Pharmacists Provide Better Care
Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.
FDA Approves Chenodiol for Treatment of Cerebrotendinous Xanthomatosis
Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.
FDA Says Ozempic, Wegovy Shortage Resolved
Semaglutide has been in shortage since 2022 due to increased demand.
Q&A: Innovative Technologies Revolutionizing Pain Medicine
Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.
Texas Health Department Investigating Measles Outbreak as Case Count Reaches 90
Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.
Multimodal Regimen Crucial for Treating Burn Injury-Induced Pain
Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.
Tirzepatide Shows Substantial Weight Loss for Patients With Type 1 Diabetes
Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.
Cardiovascular Practice Program Could Help Pharmacists Lower Patient Blood Pressure
A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.
Entrepreneurship Necessary to Community Pharmacy Practice, Education
Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.
Type 1 Diabetes Linked With Increased Dementia Risk
A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.
FDA Grants Breakthrough Therapy Designation to SkinTE for Wagner Grade 1 Diabetic Foot Ulcers
By 12 weeks, investigators report that SkinTE facilitated significantly more wound closures compared with the standard of care.
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to Care
A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Community Pharmacies Motivated to Adopt Opioid Overdose Prevention Practices
Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.
ChatGPT Could Help Community Pharmacists Save Time
Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.
FDA Accepts New Drug Application for Vatiquinone to Treat Friedreich Ataxia
The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.
GLP-1 Oral Tablet Shows Favorable Safety Findings in Patients With Obesity
ASC30, an investigational glucagon-like 1-peptide receptor agonist, demonstrates mean weight reductions from baseline of 4.3% and 6.3% for 2 separate cohorts.
FDA to Evaluate Lenacapavir for Prevention of HIV
A PDUFA target action date for the PrEP therapy has been set for June 19, 2025.
Cryotherapy Spray Reduced Pain, Improved Joint Mobility
Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.
Maximum (Un)Fair Price
How pharmacies will pay for the Medicare Drug Price Negotiation Program
Deucravacitinib Safety, Efficacy for Plaque Psoriasis Remains Consistent Up to 5 Years
The FDA initially approved deucravacitinib (Sotyktu) in September 2022 to treat moderate-to-severe plaque psoriasis.
Your 2025 Pharmacy Legislation Update
Explore key legislative actions changing pharmacy practice in 2025 and beyond.
Buprenorphine Option Did Not Improve Pain, Reduce Opioid Dosage
Patients prescribed high-dose opioids were given the option to switch to buprenorphine in hopes of improving pain and reducing opioid dosage.
